Lynne Strasfeld

Lynne Strasfeld

Auto-generated profile, based on publicly available information

Lynne Strasfeld

Oregon Health & Science University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Infectious Disease Clinics of North America
Verified
Journal Article
Closed access
LSLynne Strasfeld
Lynne Strasfeld
SCSunwen Chou
Sunwen Chou

1 September 2010 in Infectious Disease Clinics of North America
Verified
Journal Article
Closed access
LSLynne Strasfeld
Lynne Strasfeld
SCSunwen Chou
Sunwen Chou

8 October 2022 in Best Practice & Research Clinical Haematology
Verified
Journal Article
Closed access
LSLynne Strasfeld
Lynne Strasfeld

7 September 2020 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
NTNicole M. Theodoropoulos
Nicole M. Theodoropoulos
RHRicardo M. La Hoz
Ricardo M. La Hoz
CWCameron Wolfe
Cameron Wolfe
GVGabriel Vece
Gabriel Vece
RBRemzi Bag
Remzi Bag
MMMarian G. Michaels
Marian G. Michaels

9 October 2019 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
JPJoseph B. Pryor
Joseph B. Pryor
AOAli J. Olyaei
Ali J. Olyaei
DKDenise Kirsch
Denise Kirsch
LSLynne Strasfeld
Lynne Strasfeld

1 January 2021 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
CNChad D. Nix
Chad D. Nix
WMWilliam B. Messer
William B. Messer
MHMolly L. Hale
Molly L. Hale
JLJames S. Lewis
James S. Lewis
LSLynne M. Strasfeld
Lynne M. Strasfeld
Clostridioides difficile infection rates are higher in hospitalized hematopoietic stem cell transplantation (HSCT) recipients and patients with hematologic malignancy (HM) compared with the general population. This is related both to extensive exposure to antibiotics as well as to frequent and often prolonged hospitalization. In this population, with numerous potential causes of diarrhea, a subset of C difficile detected is presumed to represent colonization rather than clinical infection. The use of decision support tools to guide ordering in hospitalized patients has been reported to decrease both C difficile testing and detection rates. Following implementation of a computerized decision support tool on our HSCT/HM unit, we observed a >2-fold decrease in C difficile testing volume and National Healthcare Safety Network-defined laboratory identifications of C difficile. Furthermore, the rate of oral vancomycin use, as well as the incidence of vancomycin-resistant enterococci colonization and bloodstream infection, decreased in the postintervention period. © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.